- World rank, all time
- #28,588 of 34,923
- Rank in United States
- #6,004 of 7,310
- Research works
- 154 ▲ 158% vs 2018-21
- Citations
- 4.2k 27.0 per fractional work
- Top-10% rate
- 9.5% all institutions 10.0%
- vs its own fields
- 0.95× 1.00× is exactly expected
- Open access
- 44% world 40%
- International
- 24% world 18%
Which fields of science does TetraLogic Pharmaceuticals (United States) work in?
In 2022-now, 49% of research at TetraLogic Pharmaceuticals (United States) is in Health Sciences, 18% in Physical Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (12%), Mathematics (9%). It does 1.9× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 18 fields, with their numbers
- Health Sciences2448.7%
- Medicine2245.0%
- Health Professions23.5%
- Dentistry00.1%
- Physical Sciences918.3%
- Mathematics49.1%
- Computer Science36.9%
- Environmental Science11.1%
- Engineering00.7%
- Materials Science00.3%
- Chemistry00.3%
- Life Sciences917.9%
- Social Sciences715.1%
- Economics, Econometrics and Finance48.9%
- Psychology12.9%
- Social Sciences11.6%
- Decision Sciences01.0%
- Arts and Humanities00.7%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 7.7×. Every wedge is a field page.
All 18 fields, with their numbers
- Mathematics7.70×4 works
- Pharmacology, Toxicology and Pharmaceutics4.79×1 works
- Economics, Econometrics and Finance4.18×4 works
- Medicine2.34×22 works
- Neuroscience2.26×2 works
- Biochemistry, Genetics and Molecular Biology2.19×6 works
- Health Professions1.33×2 works
- Decision Sciences0.99×0 works
- Psychology0.94×1 works
- Immunology and Microbiology0.89×0 works
- Computer Science0.88×3 works
- Dentistry0.28×0 works
- Arts and Humanities0.23×0 works
- Environmental Science0.22×0 works
- Chemistry0.19×0 works
- Social Sciences0.13×1 works
- Materials Science0.09×0 works
- Engineering0.05×0 works
- Mathematics 7.7×
- Pharmacology, Toxicology and Pharmaceutics 4.8×
- Economics, Econometrics and Finance 4.2×
- Medicine 2.3×
- Neuroscience 2.3×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Health Professions 1.3×
- Decision Sciences 1.0×
- Psychology 0.9×
- Immunology and Microbiology 0.9×
- Computer Science 0.9×
- Dentistry 0.3×
- Arts and Humanities 0.2×
- Environmental Science 0.2×
- Chemistry 0.2×
- Social Sciences 0.1×
- Materials Science 0.1×
- Engineering 0.1×
Who are the top researchers at TetraLogic Pharmaceuticals (United States)?
Ranked on the quality score, Srinivas K. Chunduru, Suzanne B. Hendrix and Mark A. McKinlay lead among researchers whose main affiliation is TetraLogic Pharmaceuticals (United States).
- 1
Srinivas K. Chunduru
United States · #496,792 worldwide 3.3k citations · 100 works
- 2
Suzanne B. Hendrix
United States · #566,317 worldwide 5.9k citations · 275 works
- 3
Mark A. McKinlay
United States · #602,424 worldwide 4.3k citations · 95 works
- 4
Christopher A. Benetatos
United States · #823,144 worldwide 3k citations · 51 works
- 5
Samuel P. Dickson
United States · #845,145 worldwide 2.6k citations · 81 works
- 6
Stephen M. Condon
United States · #866,915 worldwide 3.8k citations · 83 works
- 7
Jessie Nicodemus‐Johnson
United States · #1,338,983 worldwide 946 citations · 42 works
- 8
Martin A. Graham
United States · #1,465,082 worldwide 865 citations · 39 works
- 9
Guangyao Yu
United States · #1,987,320 worldwide 804 citations · 27 works
- 10
Noel Ellison
United States · #2,190,929 worldwide 1.1k citations · 41 works
Which keywords describe research at TetraLogic Pharmaceuticals (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Alzheimer's Disease, Biomarkers, Oxidative Stress, Neurodegeneration, Aging, Neuroimaging, Cognitive Training and Dementia.
- Neurological Disorders
- Clinical Trials
- Acetylcholinesterase
- Dopaminergic Neurons
- Propensity Score
- Diagnostic Criteria
- False Discovery Rate
- Virtual Screening
- Molecular Docking
- Medicinal Chemistry
- Phosphoethanolamine
- Metabolic Syndrome
- Machine Learning
- Cost-effectiveness Analysis
- Tau Pathology
- Neuroinflammation
- Mild Cognitive Impairment
- Cognitive Training
- Neurodegeneration
- Biomarkers
- Alzheimer's Disease
- Oxidative Stress
- Aging
- Dementia
- Neuroimaging
- Amyloid Hypothesis
- Quality of Life
- Health Utility Measures
- Mitochondrial Dysfunction
- Cancer
- Synthetic
- Bayesian Methods
- Parkinson's Disease
- Adaptive Designs
- Causal Inference
- Neurodegenerative Diseases
- Toxicology
- a-Synuclein
- Cholinesterase Inhibitors
- Community Engagement
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Alzheimer's Disease10▲ 72×6 topics
- Biomarkers8▲ 24×6 topics
- Oxidative Stress8▲ 9.4×11 topics
- Neurodegeneration7▲ 49×5 topics
- Aging6▲ 24×7 topics
- Cognitive Training6▲ 121×2 topics
- Dementia6▲ 118×1 topic
- Mild Cognitive Impairment6▲ 132×1 topic
- Neuroimaging6▲ 41×4 topics
- Neuroinflammation5▲ 37×2 topics
- Amyloid Hypothesis5▲ 175×1 topic
- Tau Pathology5▲ 175×1 topic
- Quality of Life5▲ 6.6×5 topics
- Cost-effectiveness Analysis4▲ 96×1 topic
- Health Utility Measures4▲ 96×1 topic
- Machine Learning3▲ 1.93×4 topics
- Mitochondrial Dysfunction3▲ 20×5 topics
- Metabolic Syndrome3▲ 7.0×4 topics
- Cancer3▲ 4.0×2 topics
- Phosphoethanolamine3▲ 393×1 topic
- Synthetic3▲ 393×1 topic
- Medicinal Chemistry2▲ 17×2 topics
- Bayesian Methods2▲ 88×2 topics
- Molecular Docking2▲ 37×1 topic
- Parkinson's Disease2▲ 18×4 topics
- Virtual Screening2▲ 50×1 topic
- Adaptive Designs2▲ 201×1 topic
- False Discovery Rate2▲ 201×1 topic
- Causal Inference2▲ 102×1 topic
- Diagnostic Criteria2▲ 16×2 topics
- Neurodegenerative Diseases2▲ 23×3 topics
- Propensity Score2▲ 178×1 topic
- Toxicology2▲ 20×2 topics
- Dopaminergic Neurons2▲ 52×1 topic
- a-Synuclein2▲ 64×1 topic
- Acetylcholinesterase2▲ 146×1 topic
- Cholinesterase Inhibitors2▲ 146×1 topic
- Clinical Trials2▲ 4.5×4 topics
- Community Engagement1▲ 7.3×2 topics
- Neurological Disorders1▲ 3.7×6 topics
Which research topics does TetraLogic Pharmaceuticals (United States) publish most on?
By volume in 2022-now: Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Health Systems, Economic Evaluations, Quality of Life and Biological Research and Disease Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Dementia and Cognitive Impairment Research Psychiatry and Mental health 6 works
- 2 Alzheimer's disease research and treatments Physiology 5 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
- 4 Biological Research and Disease Studies Molecular Biology 3 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 6 Statistical Methods in Clinical Trials Statistics and Probability 2 works
- 7 Advanced Causal Inference Techniques Statistics and Probability 2 works
- 8 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
- 9 Cholinesterase and Neurodegenerative Diseases Pharmacology 2 works
- 10 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has TetraLogic Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 158% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is TetraLogic Pharmaceuticals (United States) as a percentage of every work published that year, 0.00023% in 2024.
Fractional works of TetraLogic Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Malvern
- Siemens Healthcare (United States)
- Endo Pharmaceuticals (United States)
- Immaculata University
- Ricoh (United States)
- Reaction Biology Corporation (United States)
- Applied Pulsed Power (United States)
- Saint-Gobain (United States)
- BioTelemetry (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about TetraLogic Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
